Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1953 2
1955 1
1956 1
1957 1
1962 2
1967 1
1969 1
1973 1
1975 1
1978 1
1979 1
1981 1
1982 2
1983 1
1986 1
1987 3
1989 1
2003 1
2005 1
2006 1
2009 1
2010 3
2012 3
2013 3
2014 7
2015 3
2016 3
2017 2
2018 2
2020 4
2021 6
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Optic neuritis.
Toosy AT, Mason DF, Miller DH. Toosy AT, et al. Among authors: mason df. Lancet Neurol. 2014 Jan;13(1):83-99. doi: 10.1016/S1474-4422(13)70259-X. Lancet Neurol. 2014. PMID: 24331795 Review.
Hypophosphataemia.
Lindsay SL, Mason DF. Lindsay SL, et al. Among authors: mason df. Anaesthesia. 1987 Apr;42(4):439. doi: 10.1111/j.1365-2044.1987.tb04014.x. Anaesthesia. 1987. PMID: 3592167 Free article. No abstract available.
A new era in the treatment of multiple sclerosis.
Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, Heard R, Hodgkinson S, Kermode AG, Lechner-Scott J, Macdonell RA, Marriott M, Mason DF, Parratt J, Reddel SW, Shaw CP, Slee M, Spies JM, Taylor BV, Carroll WM, Kilpatrick TJ, King J, McCombe PA, Pollard JD, Willoughby E. Broadley SA, et al. Among authors: mason df. Med J Aust. 2015 Aug 3;203(3):139-41, 141e.1. doi: 10.5694/mja14.01218. Med J Aust. 2015. PMID: 26224184 Review.
Multiple sclerosis in New Zealand.
Alla S, Mason DF. Alla S, et al. Among authors: mason df. J Clin Neurosci. 2014 Aug;21(8):1288-91. doi: 10.1016/j.jocn.2013.09.009. Epub 2013 Nov 4. J Clin Neurosci. 2014. PMID: 24503208 Review.
The neuro-otology of Susac syndrome.
Hardy TA, Taylor RL, Qiu J, O'Brien B, Gopinath S, Trewin B, Spring PJ, Shaffi M, Bolitho SJ, Garsia RJ, Roxburgh R, Mason DF, Ip J, Chan F, Chen L, Wilson I, Beadnall HN, Barnett MH, Parratt JDE, Watson JDG, Welgampola MS, Reddel SW, Tsang B, Halmagyi GM. Hardy TA, et al. Among authors: mason df. J Neurol. 2020 Dec;267(12):3711-3722. doi: 10.1007/s00415-020-10086-0. Epub 2020 Jul 21. J Neurol. 2020. PMID: 32696340
Response to treatment in NMOSD: the Australasian experience.
Clarke L, Bukhari W, O'Gorman CM, Khalilidehkordi E, Arnett S, Woodhall M, Prain KM, Parratt JDE, Barnett MH, Marriott MP, McCombe PA, Sutton I, Boggild M, Brownlee W, Carroll WM, Hodgkinson S, Macdonell RAL, Mason DF, Pereira J, Slee M, Das C, Henderson APD, Kermode AG, Lechner-Scott J; ANZ NMO Collaboration; Waters P, Sun J, Broadley SA. Clarke L, et al. Among authors: mason df. Mult Scler Relat Disord. 2022 Feb;58:103408. doi: 10.1016/j.msard.2021.103408. Epub 2021 Nov 21. Mult Scler Relat Disord. 2022. PMID: 35216788
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists.
Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, Heard R, Hodgkinson S, Kermode AG, Lechner-Scott J, Macdonell RA, Marriott M, Mason DF, Parratt J, Reddel SW, Shaw CP, Slee M, Spies J, Taylor BV, Carroll WM, Kilpatrick TJ, King J, McCombe PA, Pollard JD, Willoughby E; MS Neurology Group of the Australian and New Zealand Association of Neurologists. Broadley SA, et al. Among authors: mason df. J Clin Neurosci. 2014 Nov;21(11):1847-56. doi: 10.1016/j.jocn.2014.01.018. Epub 2014 Jun 28. J Clin Neurosci. 2014. PMID: 24986155 Review.
Multiple sclerosis mortality in New Zealand: a nationwide prospective study.
Leadbetter R, MacAskill M, Myall DJ, Taylor BV, Joshi P; NZMSPS group; Mason DF. Leadbetter R, et al. Among authors: mason df. J Neurol Neurosurg Psychiatry. 2023 Jul;94(7):511-517. doi: 10.1136/jnnp-2022-330582. Epub 2023 Mar 7. J Neurol Neurosurg Psychiatry. 2023. PMID: 36882223
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of Neurologists.
Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, Heard R, Hodgkinson S, Kermode AG, Lechner-Scott J, Macdonell RA, Marriott M, Mason DF, Parratt J, Reddel SW, Shaw CP, Slee M, Spies J, Taylor BV, Carroll WM, Kilpatrick TJ, King J, McCombe PA, Pollard JD, Willoughby E; MS Neurology Group of the Australian and New Zealand Association of Neurologists. Broadley SA, et al. Among authors: mason df. J Clin Neurosci. 2014 Nov;21(11):1857-65. doi: 10.1016/j.jocn.2014.01.017. Epub 2014 Jun 30. J Clin Neurosci. 2014. PMID: 24993136 Review.
NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand.
Bukhari W, Khalilidehkordi E, Mason DF, Barnett MH, Taylor BV, Fabis-Pedrini M, Kermode AG, Subramanian S, Waters P, Broadley SA; Australian and New Zealand NMO Collaboration. Bukhari W, et al. Among authors: mason df. J Neurol. 2022 Feb;269(2):836-845. doi: 10.1007/s00415-021-10665-9. Epub 2021 Jul 2. J Neurol. 2022. PMID: 34213614
60 results